Canada Markets close in 2 hrs 38 mins

Cronos Group Inc. (CRON)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.88-0.05 (-0.93%)
As of 1:22PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close5.93
Open5.88
Bid5.87 x 800
Ask5.88 x 4000
Day's Range5.79 - 5.96
52 Week Range4.91 - 15.83
Volume1,253,809
Avg. Volume1,650,501
Market Cap2.183B
Beta (5Y Monthly)1.83
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
  • GlobeNewswire

    Cronos Group and Ginkgo Bioworks Announce Achievement of Equity Milestone in Partnership to Produce Cultured Cannabinoids

    By achieving commercial scale production of CBG, the companies are on track to enable access to rare cannabis moleculesTORONTO and BOSTON, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cronos Group, Inc. (NASDAQ: CRON) (TSX: CRON) ("Cronos Group"), an innovative global cannabinoid company, and Ginkgo Bioworks (“Ginkgo”), which is building the leading horizontal platform for cell programming, today announced the achievement of the first target productivity milestone in their partnership to produce eight cult

  • GlobeNewswire

    Cronos Group Appoints Bob Madore as Chief Financial Officer

    TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced the appointment of Bob Madore as Chief Financial Officer, effective August 9, 2021, who will succeed Jerry Barbato. “We are pleased to add a leader of Bob’s caliber to the Cronos Group team,” said Kurt Schmidt, President and Chief Executive Officer of Cronos Group. “Bob brings to Cronos Group a proven track record of

  • GlobeNewswire

    Cronos Group Reports 2021 Second Quarter Results

    Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced strategic investment in PharmaCann, a leading U.S. cannabis company Spinach™ launched new products in the edible, concentrate, and flower categories in Canada TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), today announces its 2021 Second Quarter business results. “This quarter, Cronos Group continued to bring high-qu